The Smart Pills Technology market size is USD 4.9 Bn in 2026.
The Smart Pills Technology market is projected to grow at a CAGR of 7% by 2033.
The market growth is driven by rising incidences of colon cancer, increasing IBD cases, growing preference for minimally invasive procedures, and advancements in capsule endoscopy.
North America is the dominating region for the Smart Pills Technology market.
Medtronic plc, Boston Scientific Corporation, Olympus Corporation, Abbott Laboratories, and Siemens Healthineers are some leading industry players in the Smart Pills Technology market.